Surgical drain fluid for detection of molecular residual disease (MRD) in patients with bladder, renal, and urothelial cancers

Sponsor:

Droplet Biosciences

Sponsor Study ID:

25-003

CTO #:

104261

NCT Number:

NCT99999999

Phase:

N/A

Protocol Type:

Diagnostic

Age Group:

Adults

Disease Sites:

Bladder; Kidney; Other Urinary

Study Objectives:

To investigate if DNA cancer-associated-variants (CAV) in post-operative blood, tumor tissue, and surgical drain fluid can correlate molecular residual disease (MRD) with clinical, radiographic, or pathologic progression at 12- and 24- months post-surgery in patients with bladder, renal, and upper tract urothelial cancer.

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)